Cbdmd responds to congressional request for information (rfi) on regulation of cbd products

Washington, d.c.--(newsfile corp. - august 18, 2023) - cbdmd, inc. (nyse american: ycbd) (nyse american: ycbd-pa) (the "company"), one of the nation's leading providers of premium cannabidiol (cbd) products, today announced its direct response to the bicameral and bipartisan congressional rfi on fda regulation of cbd and urges fda to provide regulatory clarity.

YCBD Ratings Summary

YCBD Quant Ranking